Demographics (1)
- sex - Gender of participant (phv00273677.v1.p1)
Disease Events (13)
- adjuvant_therapy - Adjuvant therapy (phv00273681.v1.p1)
- AFFECTION_STATUS - Case control status of the subject for lobular or ductal carcinomas (phv00389138.v1.p1)
- age_diagnosis - Age at diagnosis (phv00273676.v1.p1)
- ESTROGEN_RECEPTOR_STATUS - Estrogen receptor status (phv00273691.v1.p1)
- HER2_STATUS - HER2 status (phv00273693.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00273688.v1.p1)
- IS_TUMOR - Tumor status (phv00273687.v1.p1)
- last_fu_status - Status at last follow-up (phv00273683.v1.p1)
- last_fu_year - Year of last follow-up (phv00273682.v1.p1)
- PROGESTERONE_RECEPTOR_STATUS - Progesterone receptor status (phv00273692.v1.p1)
- stage - Stage of disease (phv00273680.v1.p1)
- surgery - Type of surgery (phv00273678.v1.p1)
- surgery_year - Year of surgery (phv00273679.v1.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00273686.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00273685.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00273671.v1.p1)
- LATERALITY - Laterality of the breast (phv00273689.v1.p1)
- QUADRANT_BREAST - Quadrant of the breast (phv00273690.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00273684.v1.p1)
- SAMPLE_ID - Sample ID (phv00273673.v1.p1)
- SAMPLE_USE - Sample Use (phv00273674.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00273694.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00273675.v1.p1)
- SUBJECT_ID - Subject ID (phv00273670.v1.p1)
- SUBJECT_ID - Subject ID (phv00273672.v1.p1)